Stock NMRA NEUMORA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Neumora Therapeutics, Inc.

Equities

NMRA

US6409791000

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-14 pm EDT 		5-day change 1st Jan Change
9.78 USD -1.71% Intraday chart for Neumora Therapeutics, Inc. -1.71% -42.64%
May. 14 Transcript : Neumora Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:00 AM
May. 14 Neumora Therapeutics Begins Phase 2 Study of Navacaprant in Bipolar Depression MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Neumora Therapeutics Names Kaya Pai Panandiker as Chief Commercial Officer
MT
Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer
CI
Neumora Therapeutics, Inc. Appoints Jason Duncan as Chief Legal Officer
CI
Neumora Therapeutics Insider Bought Shares Worth $1,127,064, According to a Recent SEC Filing
MT
Neumora Therapeutics Insider Bought Shares Worth $25,500,000, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NMRA Stock
  4. News Neumora Therapeutics, Inc.
  5. Insiders